Lincoln Pharmaceuticals Ltd - Company Profile
Powered by 
All the sales intelligence you need on Lincoln Pharmaceuticals Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Lincoln Pharmaceuticals Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Lincoln Pharmaceuticals Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Lincoln Pharmaceuticals Ltd (Lincoln) manufactures and distributes pharmaceutical products, including medicines, injections, and related chemical and botanical products. The company’s product portfolio specializes in therapeutic areas including anti-infectives, respiratory, gynecology, cardiology, central nervous system, anti-diabetic, and anti-malarial treatments. The company offers a wide range of pharmaceutical dosage forms, including immediate and soft gelatin capsules, syrups, dry syrups, powder sachets, suspensions, semi-solids like creams, gels, ointments, as well as parenteral and topical sprays. Lincoln operates manufacturing units in Gujarat, located in Khatraj and Mahesana. Its products are exported across Europe, Latin & North America, Africa, Canada, Asia Pacific, Southeast Asia. Lincoln is headquartered in Ahmedabad, Gujarat, India.
Headquarters
India
Address
Lincoln House, B/H. Satyam Complex, Science City Road, Sola, Ahmedabad, Gujarat, 380060
Website
www.lincolnpharma.com
Telephone
91 79 41078000
No of Employees
1,853
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
LINCOLN (NSE)
Revenue (2024)
$74.5M
7.4%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-11.7%
(2024 vs 2023)
Market Cap*
$128.7M
Net Profit Margin (2024)
XYZ
-17.8%
(2024 vs 2023)
* As of and is in US$
Lincoln Pharmaceuticals Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pharmaceuticals | ARH-L |
| Therapeutic Areas: | LINQUINE-F |
| Respiratory | LINCOQUINE |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | New Products/Services | In July, the company launched Sodium Alginate & Sodium Bicarbonate Calcium oral suspension used to treat acidity, heartburn, gas, and stomach ulcers. |
| 2025 | New Products/Services | In July, the company launched Vonoprazon Fumarate Tablets for the treatment of gastrointestinal disorders. |
| 2025 | New Products/Services | In March, the company launched Telmisartan Chlorthalidone Metoprolo Succinate Tablets. |
Competitor Comparison
| Key Parameters | Lincoln Pharmaceuticals Ltd | Sun Pharmaceutical Industries Ltd | Torrent Pharmaceuticals Ltd | Abbott India Ltd | Amrutanjan Health Care Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Ahmedabad | Mumbai | Ahmedabad | Mumbai | Chennai |
| State/Province | Gujarat | Maharashtra | Gujarat | Maharashtra | Tamil Nadu |
| No. of Employees | 1,853 | 43,000 | 17,320 | 3,659 | 631 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mahendra G. Patel | Managing Director | Executive Board | 1995 | 71 |
| Darshit A. Shah | Chief Financial Officer | Senior Management | - | - |
| Trusha K. Shah | Compliance Officer; Secretary | Senior Management | - | - |
| Amit Dwivedi | Group Marketing Manager | Senior Management | - | - |
| Anil Verma | Head - Sales and Distributor | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer